English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 111 | Tables: 112 | Pharma & Healthcare
The global market for Anthrax Vaccines was valued at US$ 758 million in the year 2024 and is projected to reach a revised size of US$ 1256 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anthrax Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Vaccines.
The Anthrax Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anthrax Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anthrax Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Segment by Type
Live Vaccines
Cell free PA Vaccines
Segment by Application
Human Use
Animal Use
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anthrax Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anthrax Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Anthrax Vaccines Market Overview
1.1 Product Definition
1.2 Anthrax Vaccines by Type
1.2.1 Global Anthrax Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Anthrax Vaccines by Application
1.3.1 Global Anthrax Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Anthrax Vaccines Market Size Estimates and Forecasts
1.4.1 Global Anthrax Vaccines Revenue 2020-2031
1.4.2 Global Anthrax Vaccines Sales 2020-2031
1.4.3 Global Anthrax Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anthrax Vaccines Market Competition by Manufacturers
2.1 Global Anthrax Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anthrax Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anthrax Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anthrax Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anthrax Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Anthrax Vaccines, Date of Enter into This Industry
2.8 Global Anthrax Vaccines Market Competitive Situation and Trends
2.8.1 Global Anthrax Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anthrax Vaccines Players Market Share by Revenue
2.8.3 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anthrax Vaccines Market Scenario by Region
3.1 Global Anthrax Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anthrax Vaccines Sales by Region: 2020-2031
3.2.1 Global Anthrax Vaccines Sales by Region: 2020-2025
3.2.2 Global Anthrax Vaccines Sales by Region: 2026-2031
3.3 Global Anthrax Vaccines Revenue by Region: 2020-2031
3.3.1 Global Anthrax Vaccines Revenue by Region: 2020-2025
3.3.2 Global Anthrax Vaccines Revenue by Region: 2026-2031
3.4 North America Anthrax Vaccines Market Facts & Figures by Country
3.4.1 North America Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anthrax Vaccines Sales by Country (2020-2031)
3.4.3 North America Anthrax Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anthrax Vaccines Market Facts & Figures by Country
3.5.1 Europe Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anthrax Vaccines Sales by Country (2020-2031)
3.5.3 Europe Anthrax Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anthrax Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Anthrax Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anthrax Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Anthrax Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anthrax Vaccines Market Facts & Figures by Country
3.7.1 Latin America Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anthrax Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Anthrax Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anthrax Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Anthrax Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anthrax Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anthrax Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anthrax Vaccines Sales by Type (2020-2031)
4.1.1 Global Anthrax Vaccines Sales by Type (2020-2025)
4.1.2 Global Anthrax Vaccines Sales by Type (2026-2031)
4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Anthrax Vaccines Revenue by Type (2020-2031)
4.2.1 Global Anthrax Vaccines Revenue by Type (2020-2025)
4.2.2 Global Anthrax Vaccines Revenue by Type (2026-2031)
4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Anthrax Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anthrax Vaccines Sales by Application (2020-2031)
5.1.1 Global Anthrax Vaccines Sales by Application (2020-2025)
5.1.2 Global Anthrax Vaccines Sales by Application (2026-2031)
5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Anthrax Vaccines Revenue by Application (2020-2031)
5.2.1 Global Anthrax Vaccines Revenue by Application (2020-2025)
5.2.2 Global Anthrax Vaccines Revenue by Application (2026-2031)
5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Anthrax Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Emergent BioSolutions
6.1.1 Emergent BioSolutions Company Information
6.1.2 Emergent BioSolutions Description and Business Overview
6.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Emergent BioSolutions Anthrax Vaccines Product Portfolio
6.1.5 Emergent BioSolutions Recent Developments/Updates
6.2 Merial
6.2.1 Merial Company Information
6.2.2 Merial Description and Business Overview
6.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merial Anthrax Vaccines Product Portfolio
6.2.5 Merial Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Anthrax Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Company Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoetis Anthrax Vaccines Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Bayer Sanidad Animal
6.5.1 Bayer Sanidad Animal Company Information
6.5.2 Bayer Sanidad Animal Description and Business Overview
6.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Portfolio
6.5.5 Bayer Sanidad Animal Recent Developments/Updates
6.6 Colorado Serum
6.6.1 Colorado Serum Company Information
6.6.2 Colorado Serum Description and Business Overview
6.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Colorado Serum Anthrax Vaccines Product Portfolio
6.6.5 Colorado Serum Recent Developments/Updates
6.7 PharmAthene
6.7.1 PharmAthene Company Information
6.7.2 PharmAthene Description and Business Overview
6.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PharmAthene Anthrax Vaccines Product Portfolio
6.7.5 PharmAthene Recent Developments/Updates
6.8 Tiankang
6.8.1 Tiankang Company Information
6.8.2 Tiankang Description and Business Overview
6.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tiankang Anthrax Vaccines Product Portfolio
6.8.5 Tiankang Recent Developments/Updates
6.9 Biogénesis-Bago
6.9.1 Biogénesis-Bago Company Information
6.9.2 Biogénesis-Bago Description and Business Overview
6.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biogénesis-Bago Anthrax Vaccines Product Portfolio
6.9.5 Biogénesis-Bago Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Company Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CAVAC Anthrax Vaccines Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Rosenbusch
6.11.1 Rosenbusch Company Information
6.11.2 Rosenbusch Description and Business Overview
6.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rosenbusch Anthrax Vaccines Product Portfolio
6.11.5 Rosenbusch Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Company Information
6.12.2 Agrovet Description and Business Overview
6.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Agrovet Anthrax Vaccines Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Vecol
6.13.1 Vecol Company Information
6.13.2 Vecol Description and Business Overview
6.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vecol Anthrax Vaccines Product Portfolio
6.13.5 Vecol Recent Developments/Updates
6.14 CVCRI
6.14.1 CVCRI Company Information
6.14.2 CVCRI Description and Business Overview
6.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CVCRI Anthrax Vaccines Product Portfolio
6.14.5 CVCRI Recent Developments/Updates
6.15 IVPM
6.15.1 IVPM Company Information
6.15.2 IVPM Description and Business Overview
6.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IVPM Anthrax Vaccines Product Portfolio
6.15.5 IVPM Recent Developments/Updates
6.16 Prondil
6.16.1 Prondil Company Information
6.16.2 Prondil Description and Business Overview
6.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Prondil Anthrax Vaccines Product Portfolio
6.16.5 Prondil Recent Developments/Updates
6.17 CDV
6.17.1 CDV Company Information
6.17.2 CDV Description and Business Overview
6.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 CDV Anthrax Vaccines Product Portfolio
6.17.5 CDV Recent Developments/Updates
6.18 Indian Immunologicals
6.18.1 Indian Immunologicals Company Information
6.18.2 Indian Immunologicals Description and Business Overview
6.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Indian Immunologicals Anthrax Vaccines Product Portfolio
6.18.5 Indian Immunologicals Recent Developments/Updates
6.19 Botswana Vaccine Institute
6.19.1 Botswana Vaccine Institute Company Information
6.19.2 Botswana Vaccine Institute Description and Business Overview
6.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Portfolio
6.19.5 Botswana Vaccine Institute Recent Developments/Updates
6.20 Ceva Santé Animale
6.20.1 Ceva Santé Animale Company Information
6.20.2 Ceva Santé Animale Description and Business Overview
6.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Ceva Santé Animale Anthrax Vaccines Product Portfolio
6.20.5 Ceva Santé Animale Recent Developments/Updates
6.21 Intervac
6.21.1 Intervac Company Information
6.21.2 Intervac Description and Business Overview
6.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Intervac Anthrax Vaccines Product Portfolio
6.21.5 Intervac Recent Developments/Updates
6.22 JOVAC
6.22.1 JOVAC Company Information
6.22.2 JOVAC Description and Business Overview
6.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.22.4 JOVAC Anthrax Vaccines Product Portfolio
6.22.5 JOVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anthrax Vaccines Industry Chain Analysis
7.2 Anthrax Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anthrax Vaccines Production Mode & Process Analysis
7.4 Anthrax Vaccines Sales and Marketing
7.4.1 Anthrax Vaccines Sales Channels
7.4.2 Anthrax Vaccines Distributors
7.5 Anthrax Vaccines Customer Analysis
8 Anthrax Vaccines Market Dynamics
8.1 Anthrax Vaccines Industry Trends
8.2 Anthrax Vaccines Market Drivers
8.3 Anthrax Vaccines Market Challenges
8.4 Anthrax Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anthrax Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anthrax Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anthrax Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anthrax Vaccines Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Anthrax Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anthrax Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anthrax Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anthrax Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anthrax Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anthrax Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anthrax Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Anthrax Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anthrax Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
Table 18. Global Anthrax Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Anthrax Vaccines Sales by Region (2026-2031) & (M Doses)
Table 20. Global Anthrax Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anthrax Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Anthrax Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anthrax Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 27. North America Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
Table 28. North America Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anthrax Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Anthrax Vaccines Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Anthrax Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anthrax Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anthrax Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Anthrax Vaccines Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Anthrax Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anthrax Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anthrax Vaccines Sales (M Doses) by Type (2020-2025)
Table 51. Global Anthrax Vaccines Sales (M Doses) by Type (2026-2031)
Table 52. Global Anthrax Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Anthrax Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Anthrax Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anthrax Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anthrax Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Anthrax Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Anthrax Vaccines Price (USD/Dose) by Type (2020-2025)
Table 59. Global Anthrax Vaccines Price (USD/Dose) by Type (2026-2031)
Table 60. Global Anthrax Vaccines Sales (M Doses) by Application (2020-2025)
Table 61. Global Anthrax Vaccines Sales (M Doses) by Application (2026-2031)
Table 62. Global Anthrax Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Anthrax Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Anthrax Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anthrax Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anthrax Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Anthrax Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Anthrax Vaccines Price (USD/Dose) by Application (2020-2025)
Table 69. Global Anthrax Vaccines Price (USD/Dose) by Application (2026-2031)
Table 70. Emergent BioSolutions Company Information
Table 71. Emergent BioSolutions Description and Business Overview
Table 72. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Emergent BioSolutions Anthrax Vaccines Product
Table 74. Emergent BioSolutions Recent Developments/Updates
Table 75. Merial Company Information
Table 76. Merial Description and Business Overview
Table 77. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. Merial Anthrax Vaccines Product
Table 79. Merial Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Merck Anthrax Vaccines Product
Table 84. Merck Recent Developments/Updates
Table 85. Zoetis Company Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Zoetis Anthrax Vaccines Product
Table 89. Zoetis Recent Developments/Updates
Table 90. Bayer Sanidad Animal Company Information
Table 91. Bayer Sanidad Animal Description and Business Overview
Table 92. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. Bayer Sanidad Animal Anthrax Vaccines Product
Table 94. Bayer Sanidad Animal Recent Developments/Updates
Table 95. Colorado Serum Company Information
Table 96. Colorado Serum Description and Business Overview
Table 97. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. Colorado Serum Anthrax Vaccines Product
Table 99. Colorado Serum Recent Developments/Updates
Table 100. PharmAthene Company Information
Table 101. PharmAthene Description and Business Overview
Table 102. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. PharmAthene Anthrax Vaccines Product
Table 104. PharmAthene Recent Developments/Updates
Table 105. Tiankang Company Information
Table 106. Tiankang Description and Business Overview
Table 107. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. Tiankang Anthrax Vaccines Product
Table 109. Tiankang Recent Developments/Updates
Table 110. Biogénesis-Bago Company Information
Table 111. Biogénesis-Bago Description and Business Overview
Table 112. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 113. Biogénesis-Bago Anthrax Vaccines Product
Table 114. Biogénesis-Bago Recent Developments/Updates
Table 115. CAVAC Company Information
Table 116. CAVAC Description and Business Overview
Table 117. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 118. CAVAC Anthrax Vaccines Product
Table 119. CAVAC Recent Developments/Updates
Table 120. Rosenbusch Company Information
Table 121. Rosenbusch Description and Business Overview
Table 122. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 123. Rosenbusch Anthrax Vaccines Product
Table 124. Rosenbusch Recent Developments/Updates
Table 125. Agrovet Company Information
Table 126. Agrovet Description and Business Overview
Table 127. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 128. Agrovet Anthrax Vaccines Product
Table 129. Agrovet Recent Developments/Updates
Table 130. Vecol Company Information
Table 131. Vecol Description and Business Overview
Table 132. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 133. Vecol Anthrax Vaccines Product
Table 134. Vecol Recent Developments/Updates
Table 135. CVCRI Company Information
Table 136. CVCRI Description and Business Overview
Table 137. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 138. CVCRI Anthrax Vaccines Product
Table 139. CVCRI Recent Developments/Updates
Table 140. IVPM Company Information
Table 141. IVPM Description and Business Overview
Table 142. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 143. IVPM Anthrax Vaccines Product
Table 144. IVPM Recent Developments/Updates
Table 145. Prondil Company Information
Table 146. Prondil Description and Business Overview
Table 147. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 148. Prondil Anthrax Vaccines Product
Table 149. Prondil Recent Developments/Updates
Table 150. CDV Company Information
Table 151. CDV Description and Business Overview
Table 152. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 153. CDV Anthrax Vaccines Product
Table 154. CDV Recent Developments/Updates
Table 155. Indian Immunologicals Company Information
Table 156. Indian Immunologicals Description and Business Overview
Table 157. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 158. Indian Immunologicals Anthrax Vaccines Product
Table 159. Indian Immunologicals Recent Developments/Updates
Table 160. Botswana Vaccine Institute Company Information
Table 161. Botswana Vaccine Institute Description and Business Overview
Table 162. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 163. Botswana Vaccine Institute Anthrax Vaccines Product
Table 164. Botswana Vaccine Institute Recent Developments/Updates
Table 165. Ceva Santé Animale Company Information
Table 166. Ceva Santé Animale Description and Business Overview
Table 167. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 168. Ceva Santé Animale Anthrax Vaccines Product
Table 169. Ceva Santé Animale Recent Developments/Updates
Table 170. Intervac Company Information
Table 171. Intervac Description and Business Overview
Table 172. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 173. Intervac Anthrax Vaccines Product
Table 174. Intervac Recent Developments/Updates
Table 175. JOVAC Company Information
Table 176. JOVAC Description and Business Overview
Table 177. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 178. JOVAC Anthrax Vaccines Product
Table 179. JOVAC Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Anthrax Vaccines Distributors List
Table 183. Anthrax Vaccines Customers List
Table 184. Anthrax Vaccines Market Trends
Table 185. Anthrax Vaccines Market Drivers
Table 186. Anthrax Vaccines Market Challenges
Table 187. Anthrax Vaccines Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anthrax Vaccines
Figure 2. Global Anthrax Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anthrax Vaccines Market Share by Type: 2024 & 2031
Figure 4. Live Vaccines Product Picture
Figure 5. Cell free PA Vaccines Product Picture
Figure 6. Global Anthrax Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Anthrax Vaccines Market Share by Application: 2024 & 2031
Figure 8. Human Use
Figure 9. Animal Use
Figure 10. Global Anthrax Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anthrax Vaccines Market Size (2020-2031) & (US$ Million)
Figure 12. Global Anthrax Vaccines Sales (2020-2031) & (M Doses)
Figure 13. Global Anthrax Vaccines Average Price (USD/Dose) & (2020-2031)
Figure 14. Anthrax Vaccines Report Years Considered
Figure 15. Anthrax Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Anthrax Vaccines Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Anthrax Vaccines Players: Market Share by Revenue in Anthrax Vaccines in 2024
Figure 18. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Anthrax Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Anthrax Vaccines Sales Market Share by Country (2020-2031)
Figure 21. North America Anthrax Vaccines Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Anthrax Vaccines Sales Market Share by Country (2020-2031)
Figure 25. Europe Anthrax Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. Germany Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Anthrax Vaccines Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Anthrax Vaccines Revenue Market Share by Region (2020-2031)
Figure 33. China Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Anthrax Vaccines Sales Market Share by Country (2020-2031)
Figure 43. Latin America Anthrax Vaccines Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Anthrax Vaccines Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Anthrax Vaccines Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Anthrax Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Anthrax Vaccines by Type (2020-2031)
Figure 53. Global Revenue Market Share of Anthrax Vaccines by Type (2020-2031)
Figure 54. Global Anthrax Vaccines Price (USD/Dose) by Type (2020-2031)
Figure 55. Global Sales Market Share of Anthrax Vaccines by Application (2020-2031)
Figure 56. Global Revenue Market Share of Anthrax Vaccines by Application (2020-2031)
Figure 57. Global Anthrax Vaccines Price (USD/Dose) by Application (2020-2031)
Figure 58. Anthrax Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
